Author

K. Beider

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Nagler· 2 shared A. Arbiv· 1 shared A. Hendel· 1 shared A. Lev· 1 shared A. Zipin-Roitman· 1 shared C. Katz-Even· 1 shared C. Waskow· 1 shared D. Allen· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. Nagler

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mesenchymal Stromal Cells regulate human Hematopoietic Stem Cell survival, engraftment and regeneration via PGE2/cAMP signaling pathway

S. S. N. A. MUDDINENI, C. Katz-Even, A. Zipin-Roitman, D. Rasoulouniriana, D. S. Roy, R. Aborgies, E. Weizman, K. Beider, R. Chen, G. Hershkovitz, Y. Shulman, N. Solomon, Y. Raz, C. Waskow, A. Nagler, M. Milyavsky

This study shows that mesenchymal stromal cells protect human hematopoietic stem cells from radiation damage via the PGE2/cAMP signaling pathway, enhancing their survival and engraftment.

bioRxiv · Nov 9, 2023Cell Biology

Multiplex HDR for Disease and Correction Modeling of SCID by CRISPR Genome Editing in Human HSPCs

O. Iancu, D. Allen, O. Knop, Y. Zehavi, D. Breier, A. Arbiv, A. Lev, Y. N. Lee, K. Beider, A. Nagler, R. Somech, A. Hendel

This paper models SCID and tests gene correction in human HSPCs using CRISPR-Cas9 and multiplexed HDR, showing successful T-cell development from corrected cells.

bioRxiv · Oct 7, 2022Bioengineering